Who are Tanreqing capsule's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Louxiangdan Tongxin granules, Abelmoschus manihot (AM), Placebo of Gastrodia and Uncaria granule, Shenlingcao Oral Liquid, Shuxinin injection, Erigeron breviscapus injection.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tanreqing-capsule.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Tanreqing capsule — Competitive Intelligence Brief

Tanreqing capsule (Tanreqing capsule) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Traditional Chinese medicine. Area: Respiratory.

phase 3 Traditional Chinese medicine Respiratory Small molecule Live · refreshed every 30 min

Target snapshot

Tanreqing capsule (Tanreqing capsule) — Jiangsu Famous Medical Technology Co., Ltd.. Tanreqing capsule is used to treat cough and other respiratory symptoms by modulating the body's immune response and reducing inflammation.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Tanreqing capsule TARGET	Tanreqing capsule	Jiangsu Famous Medical Technology Co., Ltd.	phase 3	Traditional Chinese medicine
Louxiangdan Tongxin granules	Louxiangdan Tongxin granules	Liaoning University of Traditional Chinese Medicine	marketed	Traditional Chinese medicine herbal formulation
Abelmoschus manihot (AM)	Abelmoschus manihot (AM)	Chinese PLA General Hospital	marketed	Herbal extract / Traditional Chinese Medicine
Placebo of Gastrodia and Uncaria granule	Placebo of Gastrodia and Uncaria granule	Shanghai Institute of Hypertension	marketed	Herbal medicine / Traditional Chinese medicine
Shenlingcao Oral Liquid	Shenlingcao Oral Liquid	West China Hospital	marketed	Traditional Chinese Medicine	Immune system
Shuxinin injection	Shuxinin injection	Peking University Third Hospital	marketed	Traditional Chinese medicine injection
Erigeron breviscapus injection	Erigeron breviscapus injection	Guangzhou University of Traditional Chinese Medicine	marketed	Traditional Chinese medicine extract; antiplatelet/microcirculation enhancer

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Traditional Chinese medicine class)

Shanghai University of Traditional Chinese Medicine · 2 drugs in this class
Jiangsu Famous Medical Technology Co., Ltd. · 2 drugs in this class
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · 1 drug in this class
Sichuan Jishengtang Pharmaceutical Co., Ltd. · 1 drug in this class
Tasly Pharmaceutical Group Co., Ltd · 1 drug in this class
China Academy of Chinese Medical Sciences · 1 drug in this class
The First Affiliated Hospital of Guangzhou Medical University · 1 drug in this class
Dongzhimen Hospital, Beijing · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Tanreqing capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/tanreqing-capsule. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab